Search - tctmd.com

Displaying 461 - 480 of 946

Sort: Relevancy | Date

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

News Industry News

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Industry News

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

September 13, 2014

News Industry News

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

September 13, 2014

News Industry News

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

September 13, 2014

News Daily News

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

Presentation ESC 2014

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Presenter: Biner S. Finkelstein

September 03, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

News Industry News

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

September 03, 2014

News Daily News

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Yael L. Maxwell

September 02, 2014

News Daily News

Valorar la Calcificación de la Válvula Aórtica Podría Ayudar a Predecir la Fuga Paravalvular post-TAVR

Yael L. Maxwell

September 02, 2014

Advertisement

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Clinical Trial Examines the Long Term Outcomes of a Self-Expanding Transcatheter Aortic Valve in Inoperable Patients with Aortic Stenosis

Cerebral Protection Device Reduces Brain Injury Risk in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

5 Year Data from Clinical Trial Studying TAVR in Patients with Severe Aortic Stenosis Demonstrates Persistent Mortality Benefit and Lower Rate of Repeat Hospitalizations Compared to Standard Therapy

Incomplete Revascularization Linked to Poorer Outcomes in TAVR Patients With CAD

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

评估主动脉瓣膜钙化可帮助预测TAVR后血管周围泄漏

Valorar la Calcificación de la Válvula Aórtica Podría Ayudar a Predecir la Fuga Paravalvular post-TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content